EP2991666
Síalýleruð glýkóprótín
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.5.2014EP published:
25.3.2020EP application number:
14792116.7
EP translation filed:
30.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
30.4.2034Expiry date:
30.4.2025
Title:
SIALYLATED GLYCOPROTEINS
Timeline
Today
1.5.2014EP application
25.3.2020EP Publication
30.4.2020Translation submitted
15.5.2020Registration published
30.4.2025Expires
Owner
Name:
Momenta Pharmaceuticals, Inc.Address:
301 Binney Street, Cambridge, MA 02142, US
Inventor
Name:
BHATNAGAR, NaveenAddress:
Framingham, MA 01701, US
Name:
MECCARIELLO, RobinAddress:
Brighton, MA 02135, US
Name:
LANSING, Jonathan, C.Address:
Reading, MA 01867, US
Name:
ORTIZ, DanielAddress:
Stoneham MA 02180-1120, US
Name:
SARVAIYA, HetalAddress:
Quincy, MA 02169, US
Name:
WASHBURN, NathanielAddress:
Littleton, MA 01460, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361818563 PDate:
2.5.2013Country:
US
Classification
Categories:
A61K 38/14, C12N 9/10, C12P 21/00, C12Q 1/48, C07K 16/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.4.2020
Expires: 30.4.2021
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.4.2021
Expires: 30.4.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.4.2022
Expires: 30.4.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.4.2023
Expires: 30.4.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 19.4.2024
Expires: 30.4.2025
Payer: Árnason Faktor ehf.